The Vanguard Group 13D and 13G filings for Anavex Life Sciences Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Anavex Life Sciences Corp. AVXL |
The Vanguard Group | 4,360,648 5.310% |
216,148 (+5.22%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Anavex Life Sciences Corp. AVXL |
The Vanguard Group | 4,144,500 5.320% |
302,930 (+7.89%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Anavex Life Sciences Corp. AVXL |
The Vanguard Group | 3,841,570 5.050% |
3,841,570 (New Position) |
Filing |